ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Ensysce Biosciences, Inc. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -211.10% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -8.23
2
The company has declared Negative results for the last 3 consecutive quarters
- NET SALES(9M) At USD 3.34 MM has Grown at -44.78%
- PRE-TAX PROFIT(Q) At USD -3.56 MM has Fallen at -81.87%
- NET PROFIT(Q) At USD -3.56 MM has Fallen at -81.87%
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -87.08%, its profits have fallen by -38.1%
4
Below par performance in long term as well as near term
- Along with generating -87.08% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Ensysce Biosciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Ensysce Biosciences, Inc.
-87.08%
-0.85
113.59%
S&P 500
22.24%
1.67
13.28%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
19.79%
EBIT Growth (5y)
-211.10%
EBIT to Interest (avg)
-8.23
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.92
Sales to Capital Employed (avg)
1.43
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
26.33%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.59
EV to EBIT
-0.06
EV to EBITDA
-0.06
EV to Capital Employed
-0.61
EV to Sales
0.14
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-912.10%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Sideways
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET PROFIT(HY)
Higher at USD -6.32 MM
RAW MATERIAL COST(Y)
Fallen by -9,932% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 427.95 times
EPS(Q)
Highest at USD -0.52
-17What is not working for the Company
NET SALES(9M)
At USD 3.34 MM has Grown at -44.78%
PRE-TAX PROFIT(Q)
At USD -3.56 MM has Fallen at -81.87%
NET PROFIT(Q)
At USD -3.56 MM has Fallen at -81.87%
ROCE(HY)
Lowest at -870.19%
DEBT-EQUITY RATIO
(HY)
Highest at 155.71 %
Here's what is working for Ensysce Biosciences, Inc.
EPS
Highest at USD -0.52
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Highest at 427.95 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -9,932% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Ensysce Biosciences, Inc.
Net Sales
At USD 3.34 MM has Grown at -44.78%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Pre-Tax Profit
At USD -3.56 MM has Fallen at -81.87%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -3.56 MM has Fallen at -81.87%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
Debt-Equity Ratio
Highest at 155.71 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
